288
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA

, , , , &
Pages 1-10 | Received 26 Feb 2012, Accepted 30 Jun 2012, Published online: 19 Oct 2012

References

  • Ambegia, E., Ansell, S., Cullis, P., Heyes, J., Palmer, L.; MacLachlan, I. (2005). Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim Biophys Acta 1669:155–163.
  • Burvenich, I., Schoonooghe, S., Cornelissen, B., Blanckaert, P., Coene, E., Cuvelier, C., Mertens, N., et al. (2005). In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. Clin Cancer Res 11:7288–7296.
  • Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., Cattel, L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 63:19–30.
  • Diagaradjane, P., Orenstein-Cardona, J. M., Colon-Casasnovas, N. E., Deorukhkar, A., Shentu, S., Kuno, N., et al. (2008). Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 14:731–741.
  • Dos Santos, N., Allen, C., Doppen, A. M., Anantha, M., Cox, K. A., Gallagher, R. C., et al. (2007). Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta 1768:1367–1377.
  • Fu, J., Li, D., Xia, S., Song, H., Dong, Z., Chen, F., et al. (2009). Absolute quantification of plasmid DNA by real-time PCR with genomic DNA as external standard and its application to a biodistribution study of an HIV DNA vaccine. Anal Sci 25:675–680.
  • Fundaro, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., Gasco, M. R. (2000). Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res 42:337–343.
  • Gillies, E. R., Dy, E., Frechet, J. M., Szoka, F. C. (2005). Biological evaluation of polyester dendrimer: poly(ethylene oxide) “bow-tie” hybrids with tunable molecular weight and architecture. Mol Pharm 2:129–138.
  • He, X. Q., Chen, G. M., Huang, Y., Yang, F. Q., Wu, L. Y., Mo, G. Y. (2003). Construction and identification of therapeutic double plasmid HBV DNA vaccine. Med J Chin PLA 28:493–497.
  • Heyes, J., Palmer, L., Chan, K., Giesbrecht, C., Jeffs, L., MacLachlan, I. (2007). Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Mol Ther 15:713–720.
  • Ishida, T., Iden, D. L., Allen, T. M. (1999). A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett 460:129–133.
  • Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., et al. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res 65:622–631.
  • Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K. L., Nielsen, U. B., et al. (2006). Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 66:6732–6740.
  • Klibanov, A. L., Maruyama, K., Torchilin, V. P., Huang, L. (1990). Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237.
  • Kostarelos, K., Miller, A. D. (2005). Synthetic, self-assembly ABCD nanoparticles: a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev 34:970–994.
  • Lee, C. M., Choi, Y., Huh, E. J., Lee, K. Y., Song, H. C., Sun, M. J., et al. (2005). Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation. Cancer Biother Radiopharm 20:620–628.
  • Li, S. D., Chen, Y. C., Hackett, M. J., Huang, L. (2008). Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther 16:163–169.
  • Li, S., Huang, L. (1997). In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 4:891–900.
  • Li, S. D., Huang, L. (2006). Surface-modified LPD nanoparticles for tumor targeting. Ann N Y Acad Sci 1082:1–8.
  • Li, S. D., Huang, L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496–504.
  • Lim, J., Guo, Y., Rostollan, C. L., Stanfield, J., Hsieh, J. T., Sun, X. K., et al. (2008). The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Mol Pharm 5:540–547.
  • Medarova, Z., Pham, W., Farrar, C., Petkova, V., Moore, A. (2007). In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 13:372–377.
  • Moghimi, S. M., Hunter, A. C., Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318.
  • Moghimi, S. M., Szebeni, J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–478.
  • Mosqueira, V. C., Legrand, P., Morgat, J. L., Vert, M., Mysiakine, E., Gref, R., et al. (2001). Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res 18:1411–1419.
  • Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., et al. (2004). Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11:169–183.
  • Reddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., Murthy, R. S. R. (2005). Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. J Control Release 105:185–198.
  • Sokolov, K., Follen, M., Aaron, J., Pavlova, I., Malpica, A., Lotan, R., et al. (2003). Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 63:1999–2004.
  • Song, S., Liu, D., Peng, J., Deng, H., Guo, Y., Xu, L. X., et al. (2009). Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo. FASEB J 23:1396–1404.
  • Tagawa, T., Manvell, M., Brown, N., Keller, M., Perouzel, E., Murray, K. D., et al. (2002). Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu, and plasmid DNA. Gene Ther 9:564–576.
  • Torchilin,V. P. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532–1555.
  • Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A., Jr., Trubetskoy, V. S., Herron, J. N., et al. (1994). Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1195:11–20.
  • Veiseh, M., Gabikian, P., Bahrami, S. B., Veiseh, O., Zhang, M., Hackman, R. C., et al. (2007). Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67:6882–6888.
  • Wang, C. H., Liu, C. J., Wang, C. L., Hua, T. E., Obliosca, J. M., Lee, K. H., et al. (2008). Optimizing the size and surface properties of polyethylene glycol (PEG)-gold nanoparticles by intense x-ray irradiation. J Phys Appl Phys 41:1–8.
  • Wong, H. L., Bendayan, R., Rauth, A. M., Li, Y., Wu, X. Y. (2007). Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 59:491–504.
  • Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., Yang, C. Z. (1999). Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 59:299–307.
  • Zara, G. P., Cavalli, R., Bargoni, A., Fundaro, A., Vighetto, D., Gasco, M. R. (2002). Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues. J Drug Target 10:327–335.
  • Zimmermann, T. S., Lee, A. C., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., et al. (2006). RNAi-mediated gene silencing in non-human primates. Nature 441:111–114.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.